InsidersTradesSigma
Explore the detailed record of transactions filed by Sukhtian Faisal Ghiath, Director. Officer active across 1 companies, notably Outlook Therapeutics, Inc.. In total, 3 disclosures have been logged. Total volume traded: €45k. The latest transaction was filed on 2 December 2021 — Acquisition. Regulator: SEC (Form 4). All data is free.
3 of 3 declarations
Faisal Ghiath Sukhtian is a Board Member at Outlook Therapeutics, Inc. He plays a key role in the governance of the company, contributing to strategic decision-making and overseeing operations. His expertise is valuable in guiding the company's initiatives.